Randomized phase II study of the anti-epidermal growth factor receptor monoclonal antibody cetuximab with cisplatin versus cisplatin alone in patients with metastatic triple-negative breast cancer (Q47126394)
Jump to navigation
Jump to search
scientific article published on 3 June 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized phase II study of the anti-epidermal growth factor receptor monoclonal antibody cetuximab with cisplatin versus cisplatin alone in patients with metastatic triple-negative breast cancer |
scientific article published on 3 June 2013 |
Statements
1 reference
Randomized phase II study of the anti-epidermal growth factor receptor monoclonal antibody cetuximab with cisplatin versus cisplatin alone in patients with metastatic triple-negative breast cancer (English)
1 reference
1 reference
Andreas Schneeweiss
1 reference
José Baselga
1 reference
Patricia Gómez
1 reference
Richard Greil
1 reference
Sofia Braga
1 reference
Miguel A Climent
1 reference
Bella Kaufman
1 reference
Salomon M Stemmer
1 reference
António Pêgo
1 reference
Arlene Chan
1 reference
Jean-Charles Goeminne
1 reference
Marie-Pascale Graas
1 reference
M John Kennedy
1 reference
Eva Maria Ciruelos Gil
1 reference
Angela Zubel
1 reference
Jutta Groos
1 reference
Helena Melezínková
1 reference
Ahmad Awada
1 reference
3 June 2013
1 reference
1 reference
31
1 reference
2586-2592
1 reference
20
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference